LAMC2

laminin subunit gamma 2

Summary

Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), have a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the gamma chain isoform laminin, gamma 2. The gamma 2 chain, formerly thought to be a truncated version of beta chain (B2t), is highly homologous to the gamma 1 chain; however, it lacks domain VI, and domains V, IV and III are shorter. It is expressed in several fetal tissues but differently from gamma 1, and is specifically localized to epithelial cells in skin, lung and kidney. The gamma 2 chain together with alpha 3 and beta 3 chains constitute laminin 5 (earlier known as kalinin), which is an integral part of the anchoring filaments that connect epithelial cells to the underlying basement membrane. The epithelium-specific expression of the gamma 2 chain implied its role as an epithelium attachment molecule, and mutations in this gene have been associated with junctional epidermolysis bullosa, a skin disease characterized by blisters due to disruption of the epidermal-dermal junction. Two transcript variants resulting from alternative splicing of the 3' terminal exon, and encoding different isoforms of gamma 2 chain, have been described. The two variants are differentially expressed in embryonic tissues, however, the biological significance of the two forms is not known. Transcript variants utilizing alternative polyA_signal have also been noted in literature. [provided by RefSeq, Aug 2011]

Known Variants961 total

rsidPosition (GRCh37)AllelesClassClinVar
rs7592178991:183,155,211G/A—uncertain significance
rs5742619461:183,155,226T/C—uncertain significance
rs22765441:183,155,228C/A—benign
rs7740262251:183,155,232G/C—uncertain significance
rs22765431:183,155,305A/G—benign
rs8860456241:183,155,348T/G—uncertain significance
rs22765421:183,155,399G/A—benign
rs12248298741:183,155,409G/A—uncertain significance
rs5675817421:183,155,449C/T—uncertain significance
rs771334721:183,155,450C/G—benign
rs7624305221:183,155,473C/T—uncertain significance
rs6845271:183,155,482A/C—benign
rs8860456251:183,155,488A/G—conflicting classifications of pathogenicity
rs15532621991:183,155,489T/C—pathogenic
rs14798082031:183,155,490G/T—likely pathogenic
rs9889662011:183,155,493T/C—likely benign
rs3744317981:183,155,496G/T—likely benign
rs25258884881:183,155,501G/A—likely pathogenic
rs5760760771:183,155,506G/A—likely benign
rs14149277601:183,155,508C/T—likely benign
rs7726188871:183,155,517C/T—likely benign
rs13525170621:183,155,523C/T—likely benign
rs7693849321:183,155,526G/C—likely benign
rs7751481931:183,155,529C/G—likely benign
rs7510524891:183,155,535G/T—conflicting classifications of pathogenicity
rs7674564371:183,155,538C/T—likely benign
rs3712963011:183,155,545C/T—uncertain significance
rs21021547311:183,155,547G/A—likely benign
rs25258897091:183,155,553C/T—likely benign
rs3765126051:183,155,556C/T—conflicting classifications of pathogenicity
rs7551922611:183,155,559G/A—likely benign
rs16581530971:183,155,561G/A—uncertain significance
rs21021547921:183,155,562G/A—likely benign
rs7791919641:183,155,565A/G—uncertain significance
rs7482576881:183,155,573C/T—likely benign
rs16581537811:183,155,574G/T—likely benign
rs25258898491:183,155,576C/T—likely benign
rs7783245211:183,155,581A/G—likely benign
rs66788881:183,155,700C/A—benign
rs614180381:183,155,717C/A—benign
rs67030541:183,155,778A/C—benign
rs37686101:183,164,473G/Aregulatory region variant—
rs10287711:183,170,948A/Cintron variant—
rs75560641:183,173,372C/G——
rs5254101:183,176,430A/T——
rs9723008261:183,176,998T/C—likely benign
rs7816005491:183,177,000T/C—likely benign
rs2013311301:183,177,007C/T—likely benign
rs21021962001:183,177,008C/T—likely benign
rs21021962041:183,177,009T/C—likely benign
rs780564731:183,177,010C/T—conflicting classifications of pathogenicity
rs25259753871:183,177,011C/T—likely benign
rs21021962101:183,177,012C/T—likely benign
rs7716138051:183,177,014A/C—pathogenic
rs7725382561:183,177,016T/C—uncertain significance
rs7607526771:183,177,017C/A—likely benign
rs12497292831:183,177,023T/C—likely benign
rs8682772531:183,177,028A/G—uncertain significance
rs1510606431:183,177,032G/A—likely benign
rs25259757651:183,177,050C/A—likely benign
rs21021963501:183,177,059G/A—likely benign
rs16589462801:183,177,062A/G—likely benign
rs13338764601:183,177,069A/G—uncertain significance
rs14658727141:183,177,071A/G—likely benign
rs21021964031:183,177,072C/T—pathogenic
rs5692916021:183,177,083T/C—likely benign
rs25259763771:183,177,105A/G—uncertain significance
rs21021965311:183,177,107T/C—likely benign
rs14372657341:183,177,116T/C—likely benign
rs25259766721:183,177,131C/A—likely pathogenic
rs1463251691:183,177,132G/A—conflicting classifications of pathogenicity
rs25259768601:183,177,137G/A—likely benign
rs16589508951:183,177,155C/A—likely pathogenic
rs21021966361:183,177,158G/T—likely benign
rs25259770481:183,177,168A/G—uncertain significance
rs25259772221:183,177,185C/T—likely benign
rs25259772351:183,177,188C/A—likely pathogenic
rs10453405141:183,177,190A/G—uncertain significance
rs1478862281:183,177,191T/C—likely benign
rs25259773831:183,177,200C/A—likely benign
rs7595094431:183,177,205G/Asplice region variantpathogenic
rs7750938931:183,177,213A/G—likely benign
rs21021968401:183,177,214A/G—likely benign
rs6473471:183,177,218G/A—benign
rs7517056721:183,177,220G/A—likely benign
rs618091491:183,177,243A/G—benign
rs1139492871:183,177,257A/G—benign
rs6357961:183,177,454T/C—benign
rs1837080461:183,177,884G/Aregulatory region variant—
rs168605371:183,180,260A/Gregulatory region variant—
rs22749821:183,184,428C/T—benign
rs22749811:183,184,524C/T—benign
rs25260059861:183,184,568C/T—likely benign
rs3682691171:183,184,571T/C—likely benign
rs120858831:183,184,573C/T—likely benign
rs7745842891:183,184,577G/T—likely benign
rs25260061471:183,184,587G/T—likely pathogenic
rs7619555221:183,184,592T/C—likely benign
rs803566831:183,184,602C/Tstop gainedpathogenic
rs16592223711:183,184,607T/A—likely pathogenic

Showing 100 of 961 variants. Use the SNP search for the full list.

Gene information from NCBI Gene. Variant classifications from ClinVar.